Taysha Gene Therapies (TSHA) Earnings
|
Expand Research on TSHA
| Next EPS Date | 11/10/26 | EPS Growth Rate | -44.4% |
|---|---|---|---|
| Average EPS % Beat Rate | -10.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.8% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/26  |
Q326 | N/A | -$0.13 | N/A | N/A | $755.56K | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.13 | -$0.12 | -$0.01 | N/A | $300K | N/A |  | | Details | |
| 5/6/26 | Q126 | -$0.12 | -$0.10 | -$0.02 | N/A | $850K | N/A | | | Details | |
| 3/9/26 |
Q425 | N/A | -$0.10 | N/A | N/A | $2.22M | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.10 | N/A | N/A | $2.22M | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.10 | N/A | N/A | $2.22M | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.10 | N/A | N/A | $2.22M | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | -$0.10 | N/A | N/A | $2.22M | N/A | N/A | N/A |
